To ascertain the relationship between plasma biomarkers and the molecular changes in cell signalling associated with a pro-inflammatory status in PT and CHD, we evaluated the mRNA transcripts of the genes CASP1 and NLRP3, which are involved in the inflammasome pathway, in PBMC from patients and healthy subjects. Here, CASP1 is linked to coronary artery disorder.